Vigilant Capital Management’s Yield10 Bioscience, Inc. Common Stock YTEN Stock Holding History

Vigilant Capital Management’s Portfolio YTEN Stock Details YTEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$9K	Buy	+167	New	+$10.9K	﹤0.01%	407

Other funds holding YTEN

Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

CWP

Concord Wealth Partners Abingdon, Virginia $873M AUM 24.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Vigilant Capital Management's YTEN Position: Q2 2023 in Review

Vigilant Capital Management opened a new position in Yield10 Bioscience, Inc. Common Stock (YTEN) in Q2 2023: 167 shares worth $9K. The stake represents ﹤0.01% of the portfolio and ranks #407 among its holdings.

12 funds tracked by Wall St. Rank hold YTEN as of Q2 2023.

Vigilant Capital Management held 167 shares of Yield10 Bioscience, Inc. Common Stock worth $9K as of Q2 2023.
Yield10 Bioscience, Inc. Common Stock was a new Vigilant Capital Management position in Q2 2023.
Yield10 Bioscience, Inc. Common Stock made up ﹤0.01% of Vigilant Capital Management's portfolio in Q2 2023, its #407 holding.
12 funds tracked by Wall St. Rank held Yield10 Bioscience, Inc. Common Stock as of Q2 2023.

Based on Vigilant Capital Management's 13F filing for Q2 2023, filed 8 Aug 2023.